HEXO Provides Update on "The Path Forward"; Announces Cost Savings Initiatives
January 19 2022 - 5:30AM
HEXO Corp. (TSX: HEXO; NASDAQ: HEXO) ("HEXO" or the “Company"), a
leading producer of high-quality cannabis products, today provided
an update on its previously announced strategic plan, "The Path
Forward", designed to solidify HEXO’s position as the number one
cannabis company in Canada by recreational market share, with the
goal of becoming the first amongst its peers to be cash flow
positive from operations.
The plan is expected to generate incremental
cash flow of approximately $37.5 million in fiscal 2022 and an
additional anticipated and approximate $135 million in fiscal 2023
for a total of $175 million over the two years, from a combination
of cost reductions and anticipated organic revenue growth.
“It is a strategic imperative for HEXO to
strengthen its capital position and restructure the Company’s
operations to ensure a path to achieving positive cash flow from
operations within the next three quarters,” said Scott Cooper,
President and CEO of HEXO. “As an organization we are making
strategic decisions quickly to ensure we have the optimal operating
footprint we need for the next phase in HEXO’s strategic evolution,
while remaining focused on the needs of customers and in our
continued efforts in product innovation.”
HEXO is committed to providing its shareholders
with updates as the Company executes the strategic plan. Today’s
announcement provides updates on two of the five strategic pillars:
(i) Streamline and Simplify the Organizational Structure, and (ii)
Reduce Manufacturing and Production Costs.
Streamline and Simplify the
Organizational Structure
To more closely align the Company’s operating
costs with its size, HEXO announced significant cost-saving
initiatives to reduce SG&A expenses. These initiatives are
expected to represent a 30% reduction in the Company’s SG&A by
Fiscal Year End 2023. These cost reductions will be achieved
through a combination of reduced reliance on outside consultants,
streamlining the organization as a new IT platform is implemented,
right-sizing the organization, and realizing the synergistic
benefits of the recent acquisitions.
Reduce Manufacturing and Production
Costs
In addition to the SG&A savings, the Company
has also identified approximately $30 million in additional savings
from optimizing HEXO’s production network and leveraging the
capacities of its recent acquisitions. Specifically, this
includes:
- Transitioning from co-packaging
agreement towards in-house production capabilities;
- Leveraging HEXO’s scale to deliver
on procurement savings; and
- Reconfiguring the Company’s
production network to achieve greater efficiencies, for example,
moving vape production and distillate production to the Redecan
facility.
Sale of Non-Core Assets and Debt
Reduction
Under the strategic plan, the Company has also
identified certain non-core assets which may be divested. The
Company intends to apply the proceeds from any such sales
principally to debt reduction.
As such, HEXO sold its 25% interest in the
Belleville Complex Inc. (“BCI”) to Olegna Holdings Inc. (“Olegna”),
for approximately $10.1 million. Olegna is the owner of the other
75% of the facility and HEXO will continue to lease the facility
for processing, manufacturing and distribution with no changes to
the existing lease arrangements. The proceeds will be used to
amortize the High Trail Note, as required under the terms of the
Note.
The sale of the Company’s interest in BCI to
Olegna is a “related party transaction” within the meaning of
Multilateral Instrument 61-101 - Protection of Minority Security
Holders in Special Transactions (“MI 61-101”)
because Olegna is majority owned and controlled by Mr. Vincent
Chiara, a director of HEXO. HEXO is relying on applicable
exemptions from the minority approval and valuation requirements of
MI 61-101 on the basis that neither the fair market value of the
subject matter of, nor the fair market value of the consideration
for, the transaction exceeds 25% of HEXO’s market
capitalization.
The sale price for the Company’s interest in BCI
was determined by an arm’s length third party appraisal.
The Company will continue to provide updates on
the progress of The Path Forward as they develop.
Forward-Looking Statements
This press release contains forward-looking information and
forward-looking statements within the meaning of applicable
securities laws ("Forward-Looking Statements"). Forward-Looking
Statements are based on certain expectations and assumptions and
are subject to known and unknown risks and uncertainties and other
factors that could cause actual events, results, performance and
achievements to differ materially from those anticipated in these
Forward-Looking Statements. Forward-Looking Statements should not
be read as guarantees of future performance or results. Readers are
cautioned not to place undue reliance on these Forward-Looking
Statements, which speak only as of the date of this press release.
The Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any Forward-Looking
Statements as a result of new information or future events, or for
any other reason.
This press release should be read in conjunction with the
management's discussion and analysis ("MD&A") and unaudited
condensed consolidated interim financial statements and notes
thereto as at and for the three months ended October 31, 2021.
Additional information about HEXO is available on the Company's
profile on SEDAR at www.sedar.com and EDGAR at www.sec.gov,
including the Company's Annual Information Form for the year ended
July 31, 2021 dated October 29, 2021.
About HEXOHEXO is an award-winning licensed
producer of innovative products for the global cannabis market.
HEXO serves the Canadian recreational market with a brand portfolio
including HEXO, Redecan, UP Cannabis, Namaste Original Stash,
48North, Trail Mix, Bake Sale, REUP and Latitude brands, and the
medical market in Canada, Israel and Malta. The Company also serves
the Colorado market through its Powered by HEXO® strategy and Truss
CBD USA, a joint venture with Molson-Coors. With the completion of
HEXO's recent acquisitions of Redecan and 48North, HEXO is a
leading cannabis products company in Canada by recreational market
share. For more information, please visit hexocorp.com.
For further information, please contact:
Investor Relations:
invest@hexo.com
www.hexocorp.com
Media Relations:
(819) 317-0526
media@hexo.com
HEXO (TSX:HEXO)
Historical Stock Chart
From Nov 2024 to Dec 2024
HEXO (TSX:HEXO)
Historical Stock Chart
From Dec 2023 to Dec 2024